Teri E Klein

Teri E Klein

UNVERIFIED PROFILE

Are you Teri E Klein?   Register this Author

Register author
Teri E Klein

Teri E Klein

Publications by authors named "Teri E Klein"

Are you Teri E Klein?   Register this Author

100Publications

3106Reads

10Profile Views

Considerations for pharmacogenomic testing in a health system.

Genet Med 2019 Aug 9;21(8):1886-1887. Epub 2019 Jan 9.

Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41436-018-0421-x
Publisher Site
http://dx.doi.org/10.1038/s41436-018-0421-xDOI Listing
August 2019

Are Randomized Controlled Trials Necessary to Establish the Value of Implementing Pharmacogenomics in the Clinic?

Clin Pharmacol Ther 2019 Aug 12;106(2):284-286. Epub 2019 Apr 12.

Department of Biomedical Data Science, Stanford University, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpt.1420DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6663600PMC
August 2019

Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy.

Clin Pharmacol Ther 2019 Jul 13;106(1):94-102. Epub 2019 Apr 13.

Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Department of Pediatrics, Children's Mercy Kansas City, Kansas City, Missouri, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpt.1409DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612570PMC
July 2019

Pharmacogenomics Clinical Annotation Tool (PharmCAT).

Clin Pharmacol Ther 2019 Jul 15. Epub 2019 Jul 15.

Department of Biomedical Data Science and Biomedical Informatics Research, School of Medicine, Stanford University, Palo Alto, CA, 94305.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpt.1568DOI Listing
July 2019

The Case for Pharmacogenetics-Guided Prescribing of Codeine in Children.

Clin Pharmacol Ther 2019 Jun 22;105(6):1300-1302. Epub 2018 Nov 22.

Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpt.1260DOI Listing
June 2019

Pharmacogene Variation Consortium Gene Introduction: NUDT15.

Clin Pharmacol Ther 2019 May 4;105(5):1091-1094. Epub 2018 Dec 4.

School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpt.1268DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465081PMC
May 2019

Pharmacogenomics in dermatology: tools for understanding gene-drug associations.

Semin Cutan Med Surg 2019 Mar 1;38(1):E19-E24. Epub 2019 Mar 1.

Department of Biomedical Data Science, Stanford School of Medicine, Stanford, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12788/j.sder.2019.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681802PMC
March 2019

The Evolution of PharmVar.

Clin Pharmacol Ther 2019 Jan 7;105(1):29-32. Epub 2018 Dec 7.

School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA.

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/cpt.1275
Publisher Site
http://dx.doi.org/10.1002/cpt.1275DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312487PMC
January 2019

PharmGKB summary: oxycodone pathway, pharmacokinetics.

Pharmacogenet Genomics 2018 10;28(10):230-237

Departments of Biomedical Data Sciences.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000351DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602093PMC
October 2018

PharmGKB summary: clozapine pathway, pharmacokinetics.

Pharmacogenet Genomics 2018 09;28(9):214-222

Departments of Biomedical Data Sciences.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000347DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449846PMC
September 2018

PharmCAT: A Pharmacogenomics Clinical Annotation Tool.

Clin Pharmacol Ther 2018 07 1;104(1):19-22. Epub 2017 Dec 1.

Biomedical and Translational Informatics Institute, Geisinger, Danville, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpt.928DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984125PMC
July 2018

PharmGKB: A worldwide resource for pharmacogenomic information.

Wiley Interdiscip Rev Syst Biol Med 2018 07 23;10(4):e1417. Epub 2018 Feb 23.

Department of Biomedical Data Sciences, Stanford University, Stanford, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/wsbm.1417DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002921PMC
July 2018

Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.

Pharmacogenomics 2018 07 19;19(10):847-860. Epub 2018 Jun 19.

Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, TN 38105, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs-2018-0028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123879PMC
July 2018

Pharmacogenomics and big genomic data: from lab to clinic and back again.

Hum Mol Genet 2018 05;27(R1):R72-R78

Department of Genetics, Stanford University, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddy116DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946941PMC
May 2018

PharmGKB summary: clobazam pathway, pharmacokinetics.

Pharmacogenet Genomics 2018 04;28(4):110-115

Departments of Biomedical Data Sciences.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000327DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5914180PMC
April 2018

Response to "Impact of CYP3A4 Genotype on Voriconazole Exposure: New Insights Into the Contribution of CYP3A4*22 to Metabolism of Voriconazole".

Clin Pharmacol Ther 2018 02 16;103(2):187. Epub 2017 Nov 16.

Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cpt.811
Publisher Site
http://dx.doi.org/10.1002/cpt.811DOI Listing
February 2018

PharmGKB summary: very important pharmacogene information for ABCG2.

Pharmacogenet Genomics 2017 11;27(11):420-427

Departments of aGenetics bBioengineering, School of Medicine, Stanford University, Stanford cDepartment of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000305DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788016PMC
November 2017

PharmGKB summary: pazopanib pathway, pharmacokinetics.

Pharmacogenet Genomics 2017 08;27(8):307-312

Departments of aBiomedical Data Sciences bBiomedical Engineering cGenetics, Stanford University, Stanford, California dDepartment of Medicine, University of Chicago, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000292DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862561PMC
August 2017

PharmGKB summary: sorafenib pathways.

Pharmacogenet Genomics 2017 06;27(6):240-246

Departments of aBiomedical Data Science bBiomedical Engineering cGenetics Stanford University, Stanford dGilead Sciences, Foster City eEvviva Sciences, San Francisco, California fInova Schar Cancer Institute and Therapeutics, Center for Personalized Health, Falls Church, Virginia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000279DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418090PMC
June 2017

PharmGKB summary: voriconazole pathway, pharmacokinetics.

Pharmacogenet Genomics 2017 05;27(5):201-209

Departments of aBiomedical Data Science bBioengineering, Stanford University, Stanford, California cIcahn School of Medicine at Mount Sinai, The Charles Bronfman Institute for Personalized Medicine dDepartment of Medicine, Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai eDepartment of Pharmacy, The Mount Sinai Hospital, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000276DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405706PMC
May 2017

PharmGKB summary: Macrolide antibiotic pathway, pharmacokinetics/pharmacodynamics.

Pharmacogenet Genomics 2017 04;27(4):164-167

Departments of aGenetics bBioengineering, School of Medicine, Stanford University, Stanford, California cDivision of Pharmaceutics, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000270DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346035PMC
April 2017

PharmGKB summary: ivacaftor pathway, pharmacokinetics/pharmacodynamics.

Pharmacogenet Genomics 2017 01;27(1):39-42

Departments of aGenetics bBioengineering, Stanford University, Stanford, California cDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio, USA dGenomics England, Queen Mary University of London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000246DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5140711PMC
January 2017

PharmGKB summary: very important pharmacogene information for MT-RNR1.

Pharmacogenet Genomics 2016 12;26(12):558-567

Departments of aGenetics bBioengineering, Stanford University, Stanford, California cDepartment of Pediatrics, Division of Medical Genetics and Genomic Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083147PMC
http://dx.doi.org/10.1097/FPC.0000000000000247DOI Listing
December 2016

Evidence and resources to implement pharmacogenetic knowledge for precision medicine.

Am J Health Syst Pharm 2016 Dec;73(23):1977-1985

Pharmacogenomics Knowledgebase (PharmGKB), Stanford University School of Medicine, Palo Alto, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2146/ajhp150977DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117674PMC
December 2016

PharmGKB summary: isoniazid pathway, pharmacokinetics.

Pharmacogenet Genomics 2016 09;26(9):436-44

Departments of aGenetics bBioengineering, Stanford University, Stanford cKeck School of Medicine of University of Southern California, Los Angeles, California, USA dDepartment of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece eDepartment of Pharmacology, University of Oxford, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000232DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970941PMC
September 2016

Population-specific single-nucleotide polymorphism confers increased risk of venous thromboembolism in African Americans.

Mol Genet Genomic Med 2016 Sep 21;4(5):513-20. Epub 2016 Jun 21.

Department of GeneticsStanford University School of MedicineStanfordCalifornia94305; Department of BioengineeringStanford University School of MedicineStanfordCalifornia94305.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mgg3.226DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023936PMC
September 2016

A twentieth anniversary tribute to PSB.

Pac Symp Biocomput 2015 :1-7

Stanford University, Shriram Center for Bioengineering and Chemical Engineering, 443 Via Ortega, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
April 2016

PharmGKB summary: very important pharmacogene information for RYR1.

Pharmacogenet Genomics 2016 Mar;26(3):138-44

Departments of aGenetics bBioengineering, Stanford University, Stanford cChildren's Hospital Oakland Research Institute and UCSF, Oakland, California dDepartment of Medicine, University of North Dakota, Fargo, North Dakota eIMAGENETICS, Sanford Healthcare, Sioux Falls, South Dakota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000198DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4738161PMC
March 2016

PharmGKB summary: succinylcholine pathway, pharmacokinetics/pharmacodynamics.

Pharmacogenet Genomics 2015 Dec;25(12):622-30

Departments of aGenetics bBioengineering, Stanford University, Stanford, California cDepartment of Anesthesiology dMoffitt Cancer Center, DeBartolo Family Personalized Medicine Institute, Tampa, Florida, USA eGenomics England, Queen Mary University of London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000170DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631707PMC
December 2015

Sequence to Medical Phenotypes: A Framework for Interpretation of Human Whole Genome DNA Sequence Data.

PLoS Genet 2015 Oct 8;11(10):e1005496. Epub 2015 Oct 8.

Stanford Center for Inherited Cardiovascular Disease, Stanford University, Stanford, California, United States of America; Stanford Cardiovascular Institute, Stanford University, Stanford, California, United States of America; Division of Cardiovascular Medicine, Stanford University, Stanford, California, United States of America; Department of Genetics, Stanford University, Stanford, California, United States of America.

View Article

Download full-text PDF

Source
http://dx.plos.org/10.1371/journal.pgen.1005496
Publisher Site
http://dx.doi.org/10.1371/journal.pgen.1005496DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598191PMC
October 2015

PharmGKB summary: peginterferon-α pathway.

Pharmacogenet Genomics 2015 Sep;25(9):465-74

Departments of aGenetics bBioengineering, Stanford University, Stanford, California cDuke Clinical Research Institute, Duke University, Durham, North Carolina, USA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/jpharmacogenetics/2015/09000/Ph
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/FPC.0000000000000158DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757589PMC
September 2015

PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses.

Pharmacogenet Genomics 2015 Aug;25(8):416-26

aDepartment of Systems Pharmacology and Translational Therapeutics, Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania Departments of bGenetics cBioengineering, Stanford University Medical Center, Stanford University, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000150DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498995PMC
August 2015

PharmGKB summary: Efavirenz pathway, pharmacokinetics.

Pharmacogenet Genomics 2015 Jul;25(7):363-76

Departments of aGenetics bBioengineering, School of Medicine, Stanford University, Stanford, California, USA cDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000145DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461466PMC
July 2015

Evidence for Clinical Implementation of Pharmacogenomics in Cardiac Drugs.

Mayo Clin Proc 2015 Jun;90(6):716-29

Center for Personalized Therapeutics, The University of Chicago, Chicago, IL; Department of Medicine, The University of Chicago, Chicago, IL; Committee on Clinical Pharmacology and Pharmacogenomics, The University of Chicago, Chicago, IL. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2015.03.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475352PMC
June 2015

PharmGKB summary: very important pharmacogene information for human leukocyte antigen B.

Pharmacogenet Genomics 2015 Apr;25(4):205-21

Departments of aGenetics bBioengineering, Stanford University, Stanford cDepartment of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000118DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356642PMC
April 2015

PharmGKB summary: very important pharmacogene information for CFTR.

Pharmacogenet Genomics 2015 Mar;25(3):149-56

Departments of aGenetics, Stanford School of Medicine bBioengineering, Stanford University, Stanford, California cDivision of Pulmonary Medicine, Cincinnati Children's Hospital Medical Center dDepartment of Pediatrics, University of Cincinnati, Cincinnati, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000112DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336773PMC
March 2015

PharmGKB summary: ibuprofen pathways.

Pharmacogenet Genomics 2015 Feb;25(2):96-106

aDepartment of Systems Pharmacology and Translational Therapeutics bInstitute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania Departments of cGenetics dBioengineering, Stanford University, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/FPC.0000000000000113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355401PMC
February 2015

Evidence synthesis and guideline development in genomic medicine: current status and future prospects.

Genet Med 2015 Jan 19;17(1):63-7. Epub 2014 Jun 19.

1] Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland, USA [2] Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/gim.2014.69DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4272332PMC
January 2015

PharmGKB summary: very important pharmacogene information for CYP4F2.

Pharmacogenet Genomics 2015 Jan;25(1):41-7

Departments of aGenetics bBioengineering, Stanford University, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000100DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261059PMC
January 2015

PharmGKB summary: gemcitabine pathway.

Pharmacogenet Genomics 2014 Nov;24(11):564-74

Departments of aGenetics bBioengineering, Stanford University, Stanford, California, USA cDepartment of Pharmacotherapy and Translational Research dCenter for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, Florida eDepartment of Molecular Pharmacology & Experimental Therapeutics, Division of Clinical Pharmacology, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000086DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189987PMC
November 2014

PharmGKB summary: uric acid-lowering drugs pathway, pharmacodynamics.

Pharmacogenet Genomics 2014 Sep;24(9):464-76

Departments of aGenetics bBioengineering, Stanford University, Stanford, California cACOS for Research, Department of Veterans Affairs Medical Center Departments of dMedicine ePharmacology/Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/FPC.0000000000000058DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122637PMC
September 2014

PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2.

Pharmacogenet Genomics 2014 Aug;24(8):409-25

Departments of aGenetics bBioengineering, Stanford University, Palo Alto, California cDepartment of Pharmacology and Toxicology and James Graham Brown Cancer Center, University of Louisville, Kentucky, USA dDepartment of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece eDepartment of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000062DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109976PMC
August 2014

PharmGKB summary: tramadol pathway.

Pharmacogenet Genomics 2014 Jul;24(7):374-80

Departments of aGenetics bBioengineering, Stanford University, Stanford, California, USA cDepartment of Anaesthesiology and Pain Medicine, Inselspital dDepartment of Clinical Research, University of Bern, Bern, Switzerland eInstitute of Clinical Pharmacology, University Medical Center, Göttingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000057DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100774PMC
July 2014

PharmGKB summary: very important pharmacogene information for SLC22A1.

Pharmacogenet Genomics 2014 Jun;24(6):324-8

aDepartment of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco Departments of bGenetics cBioengineering, Stanford University, Palo Alto, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000048DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035531PMC
June 2014

PharmGKB summary: abacavir pathway.

Pharmacogenet Genomics 2014 May;24(5):276-82

Departments of aGenetics bBioengineering, Stanford University, Stanford cDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000040DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074515PMC
May 2014

PharmGKB summary: very important pharmacogene information for UGT1A1.

Pharmacogenet Genomics 2014 Mar;24(3):177-83

Departments of aGenetics bBioengineering, Stanford University, Palo Alto, California, USA cDepartment of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, Tennessee, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091838PMC
March 2014

PharmGKB: the Pharmacogenomics Knowledge Base.

Methods Mol Biol 2013 ;1015:311-20

Department of Genetics, School of Medicine, Stanford University, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-62703-435-7_20DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084821PMC
February 2014

PharmGKB summary: ifosfamide pathways, pharmacokinetics and pharmacodynamics.

Pharmacogenet Genomics 2014 Feb;24(2):133-8

Departments of aGenetics bBioengineering, Stanford University Medical Center, Stanford, California cDepartments of Medicine, Indiana University Simon Cancer Center, Indianapolis, Indiana, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084804PMC
February 2014

Re: CYP2D6 genotyping and the use of tamoxifen in breast cancer.

J Natl Cancer Inst 2014 Feb 9;106(2):djt379. Epub 2014 Jan 9.

Affiliations of authors: Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, MO (MAP); PharmGKB, Stanford University, Palo Alto, CA (TEK).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt379DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067108PMC
February 2014

PharmGKB summary: venlafaxine pathway.

Pharmacogenet Genomics 2014 Jan;24(1):62-72

Departments of aGenetics bBioengineering, Stanford University, Stanford, California, USA cInstitute of Pharmacology of Natural Products & Clinical Pharmacology, University of Ulm, Ulm dResearch Division, Federal Institute of Drugs & Medical Devices (BfArM), Bonn, Germany eDepartment of Pharmacology and Toxicology, Institute of Biomedicine, University of Oulu, Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098656PMC
January 2014

PharmGKB summary: mycophenolic acid pathway.

Pharmacogenet Genomics 2014 Jan;24(1):73-9

aDepartment of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota Departments of bGenetics cBioengineering, Stanford University Medical Center, Stanford University, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091813PMC
January 2014

PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 8.

Pharmacogenet Genomics 2013 Dec;23(12):721-8

aDepartment of Pharmaceutical Sciences, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado Departments of bGenetics cBioengineering, Stanford University, Palo Alto, California, USA dDepartment of Clinical Pharmacology, University of Helsinki, HUSLAB, Helsinki University Central Hospital, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0b013e3283653b27DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038626PMC
December 2013

PharmGKB summary: tamoxifen pathway, pharmacokinetics.

Pharmacogenet Genomics 2013 Nov;23(11):643-7

Departments of aGenetics bBioengineering, Stanford University Medical Center, Stanford, California cDepartment of Medicine, Indiana University Simon Cancer Center, Indianapolis, Indiana, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0b013e3283656bc1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084801PMC
November 2013

PharmGKB summary: very important pharmacogene information for the epidermal growth factor receptor.

Pharmacogenet Genomics 2013 Nov;23(11):636-42

Departments of aGenetics bBioengineering, Stanford University Medical Center, Stanford, California, USA cBreakthrough Cancer Research Unit, Pangaea Biotech, Dexeus University Institute dMedical Oncology Service, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0b013e3283655091DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966564PMC
November 2013

PharmGKB summary: cyclosporine and tacrolimus pathways.

Pharmacogenet Genomics 2013 Oct;23(10):563-85

Departments of aGenetics bBioengineering, Stanford University, Stanford, California cDepartment of Pharmaceutical Sciences, School of Pharmacy dDepartment of Pathology, School of Medicine, Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, USA eSchool of Pharmacy, University of Queensland, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0b013e328364db84DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119065PMC
October 2013

PharmGKB summary: methylene blue pathway.

Pharmacogenet Genomics 2013 Sep;23(9):498-508

Department of Genetics, Stanford University, Palo Alto, CA 94304, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0b013e32836498f4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091817PMC
September 2013

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation.

Clin Pharmacol Ther 2013 Aug 19;94(2):207-10. Epub 2013 Mar 19.

Program in Personalized and Genomic Medicine and Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/clpt.2013.59DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720847PMC
August 2013

PharmGKB summary: Diuretics pathway, pharmacodynamics.

Pharmacogenet Genomics 2013 Aug;23(8):449-53

Department of Genetics, Stanford University Medical Center, Stanford, California 94305-5120, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0b013e3283636822DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084786PMC
August 2013

Pharmacogenetics of warfarin: challenges and opportunities.

J Hum Genet 2013 Jun 9;58(6):334-8. Epub 2013 May 9.

Laboratory for International Alliance, RIKEN Center for Genomic Medicine, Yokohama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jhg.2013.40DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074513PMC
June 2013

Valproic acid pathway: pharmacokinetics and pharmacodynamics.

Pharmacogenet Genomics 2013 Apr;23(4):236-41

Department of Experimental and Clinical Pharmacology, University of Minnesota-Twin Cities, Minneapolis, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0b013e32835ea0b2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3696515PMC
April 2013

PharmGKB summary: zidovudine pathway.

Pharmacogenet Genomics 2012 Dec;22(12):891-4

Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0b013e32835879a8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3696524PMC
December 2012

Metformin pathways: pharmacokinetics and pharmacodynamics.

Pharmacogenet Genomics 2012 Nov;22(11):820-7

Department of Genetics, Stanford University Medical Center, Stanford University, Stanford, California 94304, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=01213011-201211000-000
Publisher Site
http://dx.doi.org/10.1097/FPC.0b013e3283559b22DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651676PMC
November 2012

Very important pharmacogene summary for VDR.

Pharmacogenet Genomics 2012 Oct;22(10):758-63

Channing Laboratory, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0b013e328354455cDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678550PMC
October 2012

PharmGKB summary: very important pharmacogene information for GSTT1.

Pharmacogenet Genomics 2012 Aug;22(8):646-51

Department of Genetics, Stanford University Medical Center, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0b013e3283527c02DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395771PMC
August 2012

Using ODIN for a PharmGKB revalidation experiment.

Database (Oxford) 2012 23;2012:bas021. Epub 2012 Apr 23.

Institute of Computational Linguistics, Binzmuhlestrasse 171, 8050 Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/database/bas021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332569PMC
June 2012

PharmGKB summary: phenytoin pathway.

Pharmacogenet Genomics 2012 Jun;22(6):466-70

Department of Genetics, Stanford University Medical Center, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0b013e32834aeedbDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349446PMC
June 2012